It exerts its therapeutic effects by inhibiting the activity of VEGFR (vascular endothelial growth factor receptor), PDGFR (platelet-derived growth factor receptor) and various Raf-kinases, thereby reducing cell proliferation and tumor angiogenesis. This evidence concerns the gene KDR and neoplasm.